Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia
Status:
Completed
Trial end date:
2020-10-10
Target enrollment:
Participant gender:
Summary
RATIONALE: A bone marrow or umbilical cord blood transplant may be able to replace
blood-forming cells that were destroyed by chemotherapy. Giving combination chemotherapy
before a donor stem cell transplant may make the transplant more likely to work. This may be
an effective treatment for patients with high risk Fanconi's anemia.
PURPOSE: This clinical trial is studying how well combination chemotherapy works in treating
high risk patients who are undergoing a donor stem cell transplant for Fanconi's anemia.